Grace to exit healthcare with spin-off of dialysis subsidiary
This article was originally published in Clinica
National Medical Care, the dialysis subsidiary of specialty chemicals group WR Grace, will be spun-off to Grace shareholders. The board of Grace decided this was a better solution for the company and its shareholders than other options, including a proposed takeover bid from the head of the subsidiary or a merger with Vivra Medical, the number two behind NMC in its market.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.